(Q44481330)

3 December 2017

Novel therapy of focal glomerulosclerosis with mycophenolate and angiotensin blockade (English)

1 reference

3 December 2017

1 reference

Brenda Montané

1

1 reference

3 December 2017

Carolyn Abitbol

2

1 reference

3 December 2017

Jayanthi Chandar

3

1 reference

3 December 2017

José Strauss

4

1 reference

3 December 2017

Gastón Zilleruelo

5

1 reference

3 December 2017

13 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

18

1 reference

3 December 2017

8

1 reference

3 December 2017

772-777

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-003-1174-5

3 December 2017

0 references

cites work

Primary focal segmental glomerulosclerosis in children: prognostic factors

1 reference

12 December 2020

Premature acute myocardial infarction in a child with nephrotic syndrome

1 reference

12 December 2020

Angiotensin receptor blockers: pharmacology and clinical significance.

1 reference

12 December 2020

The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children

1 reference

12 December 2020

Combined mycophenolate mofetil and losartan therapy arrests established injury in the remnant kidney

1 reference

12 December 2020

Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Con

1 reference

12 December 2020

Acute and long-term complications of corticosteroid pulse therapy.

1 reference

12 December 2020

Significance of ACE genotypes and medical treatments in childhood focal glomerulosclerosis.

1 reference

12 December 2020

Multiple causes of human kidney malformations

1 reference

12 December 2020

Successful mycophenolate mofetil treatment of glomerular disease

1 reference

12 December 2020

The long-term prognosis of patients with focal segmental glomerulosclerosis

1 reference

12 December 2020

Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and eli

1 reference

12 December 2020

Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis

1 reference

12 December 2020

Dual renin-angiotensin system blockade at optimal doses for proteinuria

1 reference

12 December 2020

Standardized Percentile Curves of Body-Mass Index for Children and Adolescents

1 reference

12 December 2020

Focal segmental glomerulosclerosis

1 reference

12 December 2020

Biological effects of cyclosporin A: A new antilymphocytic agent

1 reference

12 December 2020

Aggressive, long-term cyclosporine therapy for steroid-resistant focal segmental glomerulosclerosis

1 reference

12 December 2020

Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone

1 reference

12 December 2020

Long-term outcome in children and adults with classic focal segmental glomerulosclerosis

1 reference

12 December 2020

Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable disease

1 reference

12 December 2020

Mycophenolate mofetil

1 reference

12 December 2020

Aggressive treatment of severe idiopathic focal segmental glomerulosclerosis

1 reference

12 December 2020

Effect of methylprednisolone pulse therapy on cellular immunity abnormalities in a patient with lipoid nephrosis

1 reference

12 December 2020

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

12 December 2020

A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group.

1 reference

12 December 2020

Management of focal segmental glomerulosclerosis: evidence-based recommendations.

1 reference

12 December 2020

Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil

1 reference

12 December 2020

Quantitation of proteinuria with urinary protein/creatinine ratios and random testing with dipsticks in nephrotic children.

1 reference

12 December 2020

High incidence of focal segmental glomerulosclerosis in nephrotic syndrome of childhood

1 reference

12 December 2020

The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents

1 reference

12 December 2020

Mycophenolate mofetil limits renal damage and prolongs life in murine lupus autoimmune disease

1 reference

12 December 2020

Renal dysfunction complicating the treatment of hypertension

1 reference

12 December 2020

Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up

1 reference

12 December 2020

Long-term cyclosporine A treatment of steroid-resistant and steroid-dependent nephrotic syndrome.

1 reference

12 December 2020

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

1 reference

12 December 2020

10.1007/S00467-003-1174-5

Identifiers

DOI

1 reference

3 December 2017

1 reference